Literature DB >> 31175973

HTLV-1-host interactions facilitate the manifestations of cardiovascular disease.

Fatemeh Sadat Mohammadi1, Arman Mosavat2, Mohammad Shabestari3, Sanaz Ahmadi Ghezeldasht2, Mahmoud Shabestari3, Farnaz Mozayani1, Reza Farid Hosseini4, Yousef Ali Garivani3, Farahzad Jabbari Azad5, Seyed Abdolrahim Rezaee6.   

Abstract

Atherosclerosis is a multifactorial life-threatening disease which an epidemiologic study in Northeastern Iran showed its association with HTLV-1 infection. Therefore, a cross-sectional study of 39 newly diagnosed subjects with angiography test in three groups including 14 coronary artery disease+HTLV-1+ (CAD+HTLV-1+), 8 CAD-HTLV-1+, and 17 CAD+HTLV-1- patients and 11 healthy subjects (CAD-HTLV-1-) were conducted. In the present study, Tax and proviral load (PVL) as HTLV-1 virulence factors, along with host chemokine receptor 1 (CCR1), and CCR2 were investigated. Real-time PCR TaqMan method was carried out for PVL measurement and HTLV-1-Tax, CCR1, and CCR2 expressions in peripheral blood mononuclear cells (PBMCs). Furthermore, the main risk factors, lipid profile, and complete blood count (CBC) were assessed. Expression of CCR1 in CAD+HTLV-1+ group was higher than CAD-HTLV-1+ (P = 0.01) and healthy subjects (P = 0.02). Expression of CCR1 in CAD+HTLV-1+ was higher in comparison with CAD+HTLV-1-group but did not meet 95% CI (P = 0.02), but meaningful at 91% CI. In addition, expression of CCR2 in CAD+HTLV-1+ subjects was higher than CAD-HTLV-1+ and CAD+HTLV-1- (P = 0.001, P = 0.005, respectively). In CAD+HTLV-1- subjects, CCR2 was higher than CAD-HTLV-1+ (P = 0.03). The mean PVL in CAD+HTLV-1+ group is more than CAD-HTLV-1+ (P = 0.041). In HTLV-1+ patients Tax had a positive correlation with cholesterol (R = 0.59, P = 0.01), LDL (R = 0.79, P = 0.004) and a negative correlation with HDL (R = -0.47, P = 0.04). These correlations were stronger in CAD+HTLV-1+. Findings showed that HTLV-1 could alter the expression of CCR2 and, less effect, on CCR1. Moreover, the strong correlation between CCR2 and HTLV-1-Tax with cholesterol, LDL and HDL showed that Tax as the main HTLV-1 virulence factor in cytokine deregulation might be had indirect effects on cholesterol, LDL, and HDL levels.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Coronary artery disease (CAD); HTLV-1; Iran; Real-time PCR; Tax

Mesh:

Substances:

Year:  2019        PMID: 31175973     DOI: 10.1016/j.micpath.2019.103578

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  5 in total

Review 1.  The challenge of describing the epidemiology of HTLV in the Amazon region of Brazil.

Authors:  Ricardo Ishak; Marluísa de Oliveira Guimarães Ishak; Antonio Carlos R Vallinoto
Journal:  Retrovirology       Date:  2020-02-14       Impact factor: 4.602

2.  HTLV in South America: Origins of a silent ancient human infection.

Authors:  Ricardo Ishak; Marluísa de Oliveira Guimarães Ishak; Vânia Nakauth Azevedo; Luiz Fernando Almeida Machado; Izaura Maria Cayres Vallinoto; Maria Alice Freitas Queiroz; Greice de Lemos Cardoso Costa; João Farias Guerreiro; Antonio Carlos Rosário Vallinoto
Journal:  Virus Evol       Date:  2020-07-24

3.  Brazilian Protocol for Sexually Transmitted Infections 2020: human T-cell lymphotropic virus (HTLV) infection.

Authors:  Carolina Rosadas; Carlos Brites; Denise Arakaki-Sanchez; Jorge Casseb; Ricardo Ishak
Journal:  Rev Soc Bras Med Trop       Date:  2021-05-17       Impact factor: 1.581

4.  Identification of ITGAX and CCR1 as potential biomarkers of atherosclerosis via Gene Set Enrichment Analysis.

Authors:  Sheng Yan; Lingbing Meng; Xiaoyong Guo; Zuoguan Chen; Yuanmeng Zhang; Yongjun Li
Journal:  J Int Med Res       Date:  2022-03       Impact factor: 1.671

5.  Phenotypic and functional analysis of γδ T cells in the pathogenesis of human T-cell lymphotropic virus type 1 infection.

Authors:  Matias Ruggieri; Nicolás Ducasa; Claudia Juraske; Virginia Gonzalez Polo; Carolina Berini; Maria Florencia Quiroga; Petros Christopoulos; Susana Minguet; Mirna Biglione; Wolfgang W Schamel
Journal:  Front Immunol       Date:  2022-08-11       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.